Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case–control study

Cancer Causes and Control

Volumn 26, Issue 12, 2015, Pages 1835-1844

  Colombara, Danny V ^a,b   Manhart, Lisa E ^a   Carter, Joseph J ^b   Hawes, Stephen E ^a   Weiss, Noel S ^a,b   Hughes, James P ^a   Barnett, Matt J ^b   Goodman, Gary E ^b   Smith, Jennifer S ^c   Qiao, You Lin ^d   Galloway, Denise A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d CANCER HOSPITAL   (China)

Author keywords

HPV; KI polyomavirus; Lung cancer; Merkel cell polyomavirus; WU polyomavirus

Indexed keywords

BETA CAROTENE; PLACEBO; RETINOL PALMITATE; VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FREEZE THAWING; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOASSAY; KI POLYOMAVIRUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MERKEL CELL POLYOMAVIRUS; MIDDLE AGED; MULTICENTER STUDY; MULTIPLEX LIQUID BEAD MICROARRAY ANTIBODY ASSAY; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYOMAVIRUS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; WU POLYOMAVIRUS; CLINICAL TRIAL; COMPLICATION; ISOLATION AND PURIFICATION; LUNG NEOPLASMS; PAPILLOMAVIRIDAE; RISK; SMOKING; VIROLOGY;

AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; RISK; SMOKING;

EID: 84945460653     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0676-3     Document Type: Article

References (51)

1. Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128. doi:10.1016/S0140-6736(12)61728-0
2. Moore PS, Chang Y (2010) Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 10:878–889
3. Schulz TF (2009) Cancer and viral infections in immunocompromised individuals. Int J Cancer 125:1755–1763. doi:10.1002/ijc.24741
4. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59–67. doi:10.1016/S0140-6736(07)61050-2
5. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–1100. doi:10.1126/science.1152586
6. Carter JJ, Paulson KG, Wipf GC et al (2009) Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 101:1510–1522. doi:10.1093/jnci/djp332
7. Babakir-Mina M, Ciccozzi M, Lo Presti A et al (2010) Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients. J Med Virol 82:505–509. doi:10.1002/jmv.21711
8. Allander T, Andreasson K, Gupta S et al (2007) Identification of a third human polyomavirus. J Virol 81:4130–4136. doi:10.1128/JVI.00028-07
9. Gaynor AM, Nissen MD, Whiley DM et al (2007) Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3:e64. doi:10.1371/journal.ppat.0030064
10. Helmbold P, Lahtz C, Herpel E et al (2009) Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer 45:2207–2211. doi:10.1016/j.ejca.2009.04.038
11. Joh J, Jenson AB, Moore GD et al (2010) Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol 89:222–226. doi:10.1016/j.yexmp.2010.08.001
12. Gheit T, Muñoz JP, Levican J et al (2012) Merkel cell polyomavirus in non-small cell lung carcinomas from Chile. Exp Mol Pathol 93:162–166. doi:10.1016/j.yexmp.2012.04.008
13. Hashida Y, Imajoh M, Nemoto Y et al (2013) Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer. Br J Cancer 108:629–637. doi:10.1038/bjc.2012.567
14. Babakir-Mina M, Ciccozzi M, Campitelli L et al (2009) Identification of the novel KI Polyomavirus in paranasal and lung tissues. J Med Virol 81:558–561. doi:10.1002/jmv.21417
15. Duncavage EJ, Le B, Wang D, Pfeifer JD (2009) Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol 33:1771–1777. doi:10.1097/PAS.0b013e3181ba7b73
16. Teramoto S, Kaiho M, Takano Y et al (2011) Detection of KI polyomavirus and WU polyomavirus DNA by real-time polymerase chain reaction in nasopharyngeal swabs and in normal lung and lung adenocarcinoma tissues. Microbiol Immunol 55:525–530. doi:10.1111/j.1348-0421.2011.00346.x
17. Houben R, Grimm J, Willmes C et al (2012) Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesis. J Invest Dermatol 132:254–256. doi:10.1038/jid.2011.260
18. Grulich AE, Jin F, Conway EL et al (2010) Cancers attributable to human papillomavirus infection. Sex Health 7:244–252. doi:10.1071/SH10020
19. Yuan H, Myers S, Wang J et al (2012) Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med 367:1220–1227. doi:10.1056/NEJMoa1203055
20. DiLorenzo TP, Tamsen A, Abramson AL, Steinberg BM (1992) Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol 73(Pt 2):423–428
21. Srinivasan M, Taioli E, Ragin CC (2009) Human papillomavirus type 16 and 18 in primary lung cancers—a meta-analysis. Carcinogenesis 30:1722–1728. doi:10.1093/carcin/bgp177
22. Klein F, Amin Kotb WFM, Petersen I (2009) Incidence of human papilloma virus in lung cancer. Lung Cancer 65:13–18. doi:10.1016/j.lungcan.2008.10.003
23. Zhai K, Ding J, Shi H (2015) HPV and lung cancer risk: a meta-analysis. J Clin Virol 63:84–90. doi:10.1016/j.jcv.2014.09.014
24. Vanner EA, Shroyer KR (2015) Comments on “HPV and lung cancer risk: a meta-analysis” [Zhai et al., J. Clin. Virol. (in press)]. J Clin Virol 63:91. doi:10.1016/j.jcv.2014.11.019
25. Omenn GS, Goodman GE, Thornquist MD et al (1996) Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 88:1550–1559
26. Omenn GS, Goodman G, Thornquist M et al (1994) The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 54:2038s–2043s
27. Goodman GE, Thornquist MD, Balmes J et al (2004) The beta-carotene and retinol efficacy trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 96:1743–1750. doi:10.1093/jnci/djh320
28. Waterboer T, Sehr P, Michael KM et al (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51:1845–1853. doi:10.1373/clinchem.2005.052381
29. Waterboer T, Sehr P, Pawlita M (2006) Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309:200–204. doi:10.1016/j.jim.2005.11.008
30. Antonsson A, Green AC, Mallitt K-A et al (2010) Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol 91:1849–1853. doi:10.1099/vir.0.020115-0
31. Sehr P, Zumbach K, Pawlita M (2001) A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 253:153–162
32. Hsieh FY, Bloch DA, Larsen MD (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17:1623–1634
33. Tolstov YL, Pastrana DV, Feng H et al (2009) Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 125:1250–1256. doi:10.1002/ijc.24509
34. Burnett-Hartman AN, Newcomb PA, Schwartz SM et al (2012) No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: minnesota Cancer Prevention Research Unit Polyp Study. Cancer Epidemiol Biomarkers Prev 21:1599–1601. doi:10.1158/1055-9965.EPI-12-0651
35. Syrjänen S, Waterboer T, Sarkola M et al (2009) Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol 90:1515–1526. doi:10.1099/vir.0.007823-0
36. Michael KM, Waterboer T, Sehr P et al (2008) Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 4:e1000091. doi:10.1371/journal.ppat.1000091
37. Ernst MD (2004) Permutation Methods: a basis for exact inference. Stat Sci 19:676–685. doi:10.1214/088342304000000396
38. Wilson LE, Pawlita M, Castle PE et al (2013) Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer 133:2172–2181. doi:10.1002/ijc.28215
39. Simen-Kapeu A, Surcel H-M, Koskela P et al (2010) Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer. Cancer Epidemiol Biomarkers Prev 19:1879–1881. doi:10.1158/1055-9965.EPI-10-0356
40. Anantharaman D, Gheit T, Waterboer T et al (2014) No causal association identified for human papillomavirus infections in lung cancer. Cancer Res 74:3525–3534. doi:10.1158/0008-5472.CAN-13-3548
41. Koshiol J, Rotunno M, Gillison ML et al (2011) Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst 103:501–507. doi:10.1093/jnci/djr003
42. Syrjänen K (2012) Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res 32:3235–3250
43. Korup S, Rietscher J, Calvignac-Spencer S et al (2013) Identification of a novel human polyomavirus in organs of the gastrointestinal tract. PLoS One 8:e58021. doi:10.1371/journal.pone.0058021
44. Schowalter RM, Pastrana DV, Pumphrey KA et al (2010) Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 7:509–515. doi:10.1016/j.chom.2010.05.006
45. van der Meijden E, Janssens RW, Lauber C et al (2010) Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog 6:e1001024. doi:10.1371/journal.ppat.1001024
46. Scuda N, Hofmann J, Calvignac-Spencer S et al (2011) A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol 85:4586–4590. doi:10.1128/JVI.02602-10
47. Siebrasse EA, Reyes A, Lim ES et al (2012) Identification of MW polyomavirus, a novel polyomavirus in human stool. J Virol 86:10321–10326. doi:10.1128/JVI.01210-12
48. Lim ES, Reyes A, Antonio M et al (2013) Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology 436:295–303. doi:10.1016/j.virol.2012.12.005
49. Yu G, Greninger AL, Isa P et al (2012) Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One 7:e49449. doi:10.1371/journal.pone.0049449
50. Combes J-D, Pawlita M, Waterboer T et al (2014) Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer 135:2453–2461. doi:10.1002/ijc.28888
51. Smith EM, Rubenstein LM, Haugen TH et al (2012) Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012:571862. doi:10.1155/2012/571862